ArticleBMC gastroenterology2020

Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study.

Phunchai Charatcharoenwitthaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.